CYCLERION THERAPEUTICS, INC. Severance Costs
CYCLERION THERAPEUTICS, INC. (CYCN) reported Severance Costs of $100.00 thousand for the 1-month period ending 2024-08-31, per its S-4/A filed 2026-07-22.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2026-07-22
- CYCLERION THERAPEUTICS, INC. severance costs for the quarter ending 2024-06-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. severance costs for the quarter ending 2024-03-31 was $100.00K.
- CYCLERION THERAPEUTICS, INC. severance costs for fiscal 2023 was $100.00K.
| Period end | Severance Costs 1 month | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2024-08-31 | $100.00K S-4/A · filed 2026-07-22 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $100.00K 10-Q · filed 2024-08-07 | ||
| 2024-05-31 | $100.00K S-4/A · filed 2026-07-22 | |||
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $100.00K 10-K · filed 2024-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |